Showing results (181-190 of 477) with videos related to

Sort By:
Pageof 48
Human Molecular Genetics|October 22, 2004
Transcription factor MEF2A mutations in patients with coronary artery diseaseM R Krishna Bhagavatula, Chun Fan, Gong-Qing Shen, et al.
NEJM AI|February 16, 2026
Catalyzing Health AI by Fixing Payment SystemsNarges Razavian, Prem Batchu-Green, Vikas Chowdhry, et al.
The American Journal of Medicine|February 15, 2003
An invasive strategy is associated with decreased mortality in patients with unstable angina and non-ST-elevation myocardial infarction: GUSTO IIb trialLeslie Cho, Deepak L Bhatt, Steve P Marso, et al.
Journal of the American College of Cardiology|July 31, 2007
Lack of evidence of a clopidogrel-statin interaction in the CHARISMA trialJacqueline Saw, Danielle M Brennan, Steven R Steinhubl, et al.
The American Journal of Cardiology|July 17, 2007
Impact of sex, metabolic syndrome, and diabetes mellitus on cardiovascular eventsKoon-Hou Mak, Stefan Ma, Derrick Heng, et al.
Teaching and Learning in Medicine|February 15, 2021
Medical Podcasting in Low- and Middle-Income Countries: A Needs Assessment and Vision for the FutureAdam Rodman, Hannah R Abrams, Matthew Watto, et al.
Teaching and Learning in Medicine|December 15, 2017
A Comparison of the Expectations and Experiences of Medical Students From High-, Middle-, and Low-Income Countries Participating in Global Health Clinical ElectivesMichael J Peluso, Adam Rodman, Douglas A Mata, et al.
Physiological Genomics|March 20, 2003
Proteomic approach to coronary atherosclerosis shows ferritin light chain as a significant marker: evidence consistent with iron hypothesis in atherosclerosisSun-Ah You, Stephen R Archacki, George Angheloiu, et al.
The American Journal of Cardiology|August 29, 2003
Peripheral vascular disease and one-year mortality following percutaneous coronary revascularizationJohn H Chiu, Eric J Topol, Patrick L Whitlow, et al.
The American Journal of Cardiology|February 22, 2005
Bivalirudin versus heparin and glycoprotein IIb/IIIa inhibition among patients with renal impairment undergoing percutaneous coronary intervention (a subanalysis of the REPLACE-2 trial)Derek P Chew, A Michael Lincoff, Hitinder Gurm, et al.
Pageof 48